Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

50.23

-16.35 (-24.56%)

At close: May 13, 2025, 4:00 PM

50.30

+0.07 (0.14%)

Pre-market: May 14, 2025, 6:19 AM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $6.19 billion as of May 14, 2025. Its market cap has increased by 26.89% in one year.

Market Cap

6.19B

Enterprise Value

6.98B

1-Year Change

26.89%

Ranking

#1136

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $6.19B, an increase of 76,312.23%. That is a compound annual growth rate of 36.83%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	8.20B	34.88%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	679.14B
Johnson & Johnson	360.43B
AbbVie	332.07B
UnitedHealth Group	296.19B
Novo Nordisk	292.03B
Abbott Laboratories	227.69B
Novartis AG	213.30B
AstraZeneca	210.42B

Market Cap Rankings